HIGHLIGHTS
- who: Yongjun Li and colleagues from the Department of Cardiology, Zhongda Hospital, Medical School of Southeast University, Nanjing, China have published the paper: Effects of PCSK9 Inhibition on Coronary Atherosclerosis Regression of Nontarget Lesions after Primary Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients, in the Journal: Journal of Interventional Cardiology of 26/Dec/2022
- what: In this study, after discharge, all participants underwent angiography and a comparable course of treatment within 12 months of their discharge.
- how: In this study quantitative coronary angiography was used to compare the area stenosis of nontarget . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.